{
    "title": "109_s2255",
    "content": "The Act titled \"Medicare Drug Formulary Protection Act\" allows for the removal of covered Part D drugs from the prescription drug plan formulary. The Medicare Drug Formulary Protection Act prohibits the removal of covered Part D drugs from the prescription drug plan formulary starting in 2006. The Medicare Drug Formulary Protection Act prohibits a prescription drug plan from removing covered Part D drugs from the formulary or imposing restrictions on coverage, except at the beginning of each plan year. The Medicare Drug Formulary Protection Act allows for new therapeutic uses and newly covered Part D drugs. For individuals enrolling in a prescription drug plan after the enactment date, the plan cannot remove a covered Part D drug or impose restrictions on coverage. The Medicare Drug Formulary Protection Act prohibits removing or restricting coverage of a covered Part D drug for individuals enrolling in a prescription drug plan, except as permitted by the Secretary for new therapeutic uses and newly covered drugs. The Medicare Drug Formulary Protection Act prohibits removing or restricting coverage of a covered Part D drug, except for new therapeutic uses and newly covered drugs, with exceptions for brand name drugs with generic alternatives. The Medicare Drug Formulary Protection Act prohibits removal or restriction of coverage for certain drugs, including brand name drugs going off-patent, drugs with FDA-imposed restrictions, and ineffective drugs during a specific period. The Medicare Drug Formulary Protection Act prohibits removal or restriction of coverage for certain drugs, including brand name drugs going off-patent, drugs with FDA-imposed restrictions, and ineffective drugs during a specific period. The PDP sponsor of a prescription drug plan must provide notice of any removal or change in coverage to the Secretary, affected enrollees, physicians, pharmacies, and pharmacists. The Medicare Drug Formulary Protection Act requires PDP sponsors to notify enrollees of any changes in formulary or coverage restrictions annually. This notice must be provided during the coordinated election period for the upcoming plan year."
}